Month: March 2013

Innovative Methods Can Identify Differential Responders To Treatment

Manchester, UK – In the article, “Innovative Data Analysis for Demonstrating Product Value: Analysis of Heterogeneity in Treatment Response in Clinical Trials,” published in Vol. 19 Issue 1 of ISPOR CONNECTIONS, Dr. Donald E. Stull and Katherine Houghton assessed an example of

Posted in ISPOR CONNECTIONS, Value & Outcomes Spotlight Tagged with: , , ,

Patient’s Needs For Medication Adherence Are Still Unclear

Karachi, Pakistan – Medication non-adherence is a global issue. Physicians are deemed responsible for assessing medication non-adherence, however, other health professionals, such as pharmacists may also be involved. Unfortunately, neither the health professionals nor the patients they are assessing are taking

Posted in ISPOR CONNECTIONS, Value & Outcomes Spotlight Tagged with: ,

Bayesian Methods Can Help To Bring Science Closer To Policy

Nijmegen, The Netherlands – A gap often exists between the questions that policy-makers face and the answers that science provides. Typically, science offers bits and pieces of information that are, at best, partially relevant to the policy problem under consideration.

Posted in Comparative Effectiveness Research / Health Technology Assessment, Value in Health Tagged with: , , , , ,